Momentum Stocks in Concentration: First BanCorp. (NYSE:FBP), Viking Therapeutics, Inc. (NASDAQ:VKTX)

3d blue background with stock diagram

First BanCorp. (NYSE:FBP)

First BanCorp. (NYSE:FBP) represented a move of -2.62 percent or $0.22 per share and closed its previous day trading session at $8.91. 3 Million Shares were traded in the last trading session with an Average Volume of 1.99 Million Shares. The stock currently has a Market Capitalization of 1.92 Billion.

First Bancorp distinguished itself by providing innovative marketing strategies and novel products to attract clients. Besides the branches and lending offices, the Corporation has offered a telephone information service called Telebanco since 1983. This was the first telebanking service offered in Puerto Rico. The Corporation’s clients have access to an extensive ATM network all over the world. The Corporation was the first in Puerto Rico to open on weekends and the first to offer in-store branches to its clients.

The stock traded between $4.48 and $9.38 over 1-Year time period showing its price to sales ratio of 3.2. First BanCorp. (NYSE:FBP) is currently showing an INCREASING volatility over a period of 10-Days while the 20-Days Volatility showing a DECREASING trend.

Right now, the stock has a 50-Day Simple Moving Average of $0.56 and 200-Day Simple Moving Average of $19.26. Its Price to Free Cash Flow is 7.74 and Price to Book of 1.03.

Analyst’s recommended the stock as 1.5 where 1 represents Strong Buy and 5 represents Sell.

In the last Quarter, First BanCorp. (NYSE:FBP) reported its Actual EPS of $0.14/share. The analysts offering Earnings Estimates for the company were believing that First BanCorp. could bring EPS of $0.13/share. The difference between Actual EPS and Estimated EPS was 0.01 Percent. Thus showing an Earnings Surprise of 7.7 Percent.

Viking Therapeutics, Inc. (NASDAQ:VKTX)

In the last trading session, Viking Therapeutics, Inc. (NASDAQ:VKTX) added its value by -9.56% closing at the price of $12.4. The stock currently has market capitalization of 908.3 Million, with average volume of 3.93 Million shares.

Beta is also a factor of measure of the relative volatility of a particular stock to the market. Currently Viking Therapeutics, Inc. (NASDAQ:VKTX) is showing beta of 2.9. This particular value of beta suggests that Viking Therapeutics, Inc. (NASDAQ:VKTX) has historically moved 290% for every 100% move in the benchmark, based on price level.

EPS is another important factor while making the decision of buying, selling or holding of particular share. Currently EPS for Viking Therapeutics, Inc. (NASDAQ:VKTX) is at $-0.56.

The stock currently has RSI of 37.55. RSI is considered overbought when above 70 and oversold when below 30, currently the given RSI for the stock suggests that the stock is average and it has not entered in overbought or oversold territory.

Viking Therapeutics, Inc. is a biopharmaceutical company. The company is engaged in development of novel therapies for metabolic and endocrine disorders. Its product candidate consists of VK5211, VK0214, VK0612 and VK2809 which are in different clinical trial. Viking Therapeutics, Inc. is based in LA JOLLA, United States.

Viking Therapeutics, Inc. (NASDAQ:VKTX) topped its 52-week high price of $24.00 on 09/18/18 and 52-Week Low Price of $ 2.08 on 11/08/17. The Stock currently has P/E (price to earnings ttm) of 0 and Weekly volatility of 8.92% and monthly volatility of 8.56% respectively.